- Home
- RPTX vs CGO Comparison
RPTX vs CGO Comparison
Compare RPTX & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- CGO
- Stock Information
- Founded
- RPTX 2016
- CGO 2004
- Country
- RPTX Canada
- CGO United States
- Employees
- RPTX N/A
- CGO N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- RPTX Health Care
- CGO Finance
- Exchange
- RPTX Nasdaq
- CGO Nasdaq
- Market Cap
- RPTX 63.9M
- CGO 111.0M
- IPO Year
- RPTX 2020
- CGO N/A
- Fundamental
- Price
- RPTX $1.41
- CGO $11.75
- Analyst Decision
- RPTX Strong Buy
- CGO
- Analyst Count
- RPTX 3
- CGO 0
- Target Price
- RPTX $4.50
- CGO N/A
- AVG Volume (30 Days)
- RPTX 81.7K
- CGO 34.7K
- Earning Date
- RPTX 08-05-2025
- CGO 01-01-0001
- Dividend Yield
- RPTX N/A
- CGO 9.25%
- EPS Growth
- RPTX N/A
- CGO N/A
- EPS
- RPTX N/A
- CGO N/A
- Revenue
- RPTX $1,073,000.00
- CGO N/A
- Revenue This Year
- RPTX N/A
- CGO N/A
- Revenue Next Year
- RPTX N/A
- CGO N/A
- P/E Ratio
- RPTX N/A
- CGO N/A
- Revenue Growth
- RPTX N/A
- CGO N/A
- 52 Week Low
- RPTX $0.89
- CGO $7.90
- 52 Week High
- RPTX $4.29
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- RPTX 56.42
- CGO 70.09
- Support Level
- RPTX $1.40
- CGO $11.65
- Resistance Level
- RPTX $1.45
- CGO $11.45
- Average True Range (ATR)
- RPTX 0.05
- CGO 0.14
- MACD
- RPTX -0.00
- CGO 0.02
- Stochastic Oscillator
- RPTX 63.64
- CGO 87.10
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.